Wayne,
ANP has mentioned the "broader effects of CD49d modulation by ATL1102" for over 12 months now.
But the jig saw puzzle is now finally coming together.
We'll be hearing much more about: TSP-1, LTBP4, VCAM-1, CXCL16
Soon, Big Pharma will also have the Murdoch Institute lab data with even more scientific information to make some BIG bets on new P2 ready programs.
Heart disease, LGMD, Becker, Dementia, Diabetes, Asthma, MS, Cancer.....straight into mid to end-stage development!
How many "mid-stage" P2 ready programs currently floating around? Not many!
At a time when mRNA tech is in the spotlight due to Moderna and Pfizer... ANP's timing is impeccable
20 years of toil to be an overnight success.
EMA approval next week will be a KEY catalyst that sets of a chain of events.
How long we stay independent is another question
.
Wayne, ANP has mentioned the "broader effects of CD49d...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
-0.010(13.5%) |
Mkt cap ! $57.69M | |||
| Open | High | Low | Value | Volume |
| 7.4¢ | 7.6¢ | 5.9¢ | $516.4K | 8.992M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 339429 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 143169 | 1 |
View Market Depth
| Last trade - 16.10pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
5.9¢ |
Change
-0.010 ( 21.3 %) |
||||
| Open | High | Low | Volume | ||
| 7.6¢ | 7.6¢ | 5.9¢ | 132018 | ||
| Last updated 15.49pm 25/04/2024 ? | |||||
| PER (ASX) Chart |